Research map: IL ‐6 Blockade May Suppress the Alternative Complement Pathway in Neuromyelitis Optica Spectrum Disorders

Back to the article

Papers in this map

  1. Complement System Part II: Role in Immunity · Nicolas S. Merle · 2015 · 1067 citations · Cited by this paper
  2. Not All Patients Start From the Same Line: Rethinking Outcome Interpretation in Myasthenia Gravis · 2025 · Related
  3. Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder · Takashi Yamamura · 2019 · 666 citations · Cited by this paper
  4. Involvement of Regulatory T Cells in the Pathophysiology of Myasthenia Gravis: From a Pediatrician's Perspective · 2026 · Related
  5. Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica · Norio Chihara · 2011 · 478 citations · Cited by this paper
  6. Successful Treatment of Refractory Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease With Tocilizumab: A Case Report and Literature Review · 2025 · Related
  7. Complement — tapping into new sites and effector systems · Martin V. Kolev · 2014 · 348 citations · Cited by this paper
  8. Relapse and Neurological Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease: A Retrospective Secondary Analysis of a Japanese Nationwide Epidemiologic Survey · 2026 · Related
  9. Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology · Kazuo Fujihara · 2020 · 254 citations · Cited by this paper
  10. Autoimmune Cerebellar Ataxia Following TNF ‐α Inhibitor Therapy for Rheumatoid Arthritis: A Case Report · 2026 · Related
  11. Transcriptional Regulation of Complement Genes · John E. Volanakis · 1995 · 114 citations · Cited by this paper
  12. Unveiling the Mysteries of Rare Neuroimmunological Disorders · 2025 · Related
  13. Tocilizumab reduces complement C3 and C4 serum levels in rheumatoid arthritis patients · Ciro Pasquale Romano · 2018 · 29 citations · Cited by this paper
  14. Acute Denervation Revealed by Electromyography, in Conjunction With Normal Appearing Lumbar Spinal Cord in NMOSD : Case Report · 2025 · Related
  15. Complement biomarkers reflect the pathological status of neuromyelitis optica spectrum disorders · Katsuichi Miyamoto · 2023 · 14 citations · Cited by this paper
  16. Disability, Cognition, and Quality of Life in Individuals With Multiple Sclerosis: A 2‐Year Cohort Study · 2026 · Related
  17. Tocilizumab modulates the activity of the classical and alternative complement pathways in rheumatoid arthritis patients · Iván Ferraz‐Amaro · 2025 · 8 citations · Cited by this paper
  18. Pulmonary Nodular Lymphoid Hyperplasia in a Case of Overlapping Neuromyelitis Optica Spectrum Disorder and Myasthenia Gravis · 2025 · Related
  19. Predictive complement biomarkers for relapse in neuromyelitis optica spectrum disorders · Katsuichi Miyamoto · 2025 · 5 citations · Cited by this paper
  20. Impact of Prior Intravenous Immunoglobulin and Plasmapheresis on Eculizumab or Ravulizumab Treatment for Generalized Myasthenia Gravis: An Analysis of the MG SPOTLIGHT Registry · 2025 · Related
  21. Changes in Blood Cells and Complements During Relapse Prevention Therapies for Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder · Hiroshi Kuroda · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)